Skip to Content

Logo 235 (Xospata 40 mg)

Generic Name: gilteritinib

Pill with imprint Logo 235 is Yellow, Round and has been identified as Xospata 40 mg. It is supplied by Astellas Pharma US, Inc..

Xospata is used in the treatment of acute myeloid leukemia and belongs to the drug class multikinase inhibitors. Xospata 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 235

Xospata 40 mg Logo 235
Xospata 40 mg Logo 235
Xospata 40 mg Logo 235

Xospata

Generic Name
gilteritinib
Imprint
Logo 235
Strength
40 mg
Color
Yellow
Shape
Round
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Astellas Pharma US, Inc.
National Drug Code (NDC)
00469-1425

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.